Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)
China flag China · Delayed Price · Currency is CNY
12.62
-0.49 (-3.74%)
Oct 8, 2026, 2:05 PM CST

SHA:600721 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
342.81387.43383.47366.22346.37278.13
Other Revenue
0.780.892.283.063.513.22
343.59388.32385.76369.28349.88281.35
Revenue Growth
-12.25%0.66%4.46%5.54%24.36%232.84%
Cost of Revenue
212.56237.1224.05227.84255.43184.18
Gross Profit
131.03151.22161.71141.4494.4597.17
Selling, General & Admin
65.5167.1668.473.7278.3564.51
Research & Development
21.4724.3829.5531.8727.485.25
Other Operating Expenses
5.715.135.225.254.794.65
Operating Expenses
95.32101.19131.11127.3127.1683.14
Operating Income
35.7150.0330.5914.14-32.7114.04
Interest Expense
-0.08----0.11-0.05
Interest & Investment Income
0.81.114.962.270.520.22
Currency Exchange Gain (Loss)
-0.07-0.07-0.05-0--
Other Non Operating Income (Expenses)
-0.03-0.020.57-0.6-0.66-0.37
EBT Excluding Unusual Items
36.3351.0636.0715.81-32.9713.84
Gain (Loss) on Sale of Investments
-7.39-7.3-0.130.70.010.44
Gain (Loss) on Sale of Assets
000.090.0100.01
Asset Writedown
-0.45-0.28-0.1-0.39-0.07-0.13
Legal Settlements
-0.72-0.84-0.38-0.11-0.11-0.3
Other Unusual Items
2.561.521.30.451.0248.32
Pretax Income
30.3344.1636.8616.48-32.1262.18
Income Tax Expense
0.363.47-4.613.512.622.3
Earnings From Continuing Operations
29.9640.6941.4812.97-34.7459.87
Minority Interest in Earnings
-----0.03-0.05
Net Income
29.9640.6941.4812.97-34.7659.83
Net Income to Common
29.9640.6941.4812.97-34.7659.83
Net Income Growth
-32.36%-1.91%219.75%---
Shares Outstanding (Basic)
384384382379376375
Shares Outstanding (Diluted)
384384382379376375
Shares Change
0.13%0.50%0.79%0.92%0.20%-3.79%
EPS (Basic)
0.080.110.110.03-0.090.16
EPS (Diluted)
0.080.110.110.03-0.090.16
EPS Growth
-32.45%-2.40%217.25%---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
22.2512.4255.6844.8450.7728.68
Free Cash Flow Per Share
0.060.030.150.120.140.08
Dividend Per Share
0.0400.040----
Dividend Growth
------
Gross Margin
38.14%38.94%41.92%38.30%27.00%34.54%
Operating Margin
10.39%12.88%7.93%3.83%-9.35%4.99%
Profit Margin
8.72%10.48%10.75%3.51%-9.94%21.26%
Free Cash Flow Margin
6.48%3.20%14.44%12.14%14.51%10.20%
EBITDA
53.6367.8448.935.41-7.1339.18
EBITDA Margin
15.61%17.47%12.68%9.59%-2.04%13.93%
D&A For EBITDA
17.9217.8118.321.2725.5825.14
EBIT
35.7150.0330.5914.14-32.7114.04
EBIT Margin
10.39%12.88%7.93%3.83%-9.35%4.99%
Effective Tax Rate
1.20%7.87%-21.29%-3.70%
Revenue as Reported
343.59388.32385.76369.28349.88281.35
Advertising Expenses
-1.350.141.090.840.4